Summary. Starvation of rats for 24 hrs resulted in decreased insulin release from the isolated rat pancreas. The effect of fasting could not be counteracted by elevation of the glucose level in the equilibration medium from 0.8 to 1.5 mg/ml.
The modulating effect of the adrenergic nervous system and circulating catecholamines on insulin secretion has been amply demonstrated [1] [2] [3] [4] [5] . Isolated preparations of pancreatic tissue for the study of insulin release have been used with the assumption that such an effect is negligible in vitro. However, recent studies have established that considerable quantities of catecholamines may be liberated from the isolated peffused dog pancreas [6] .
The present study was undertaken in order to evaluate the role of endogenous pancreatic catecholamines in glucose induced insulin output from the isolated rat pancreas. Furthermore, since data in the literature suggest that the diminished insulin responsiveness of the fasted animals may be due to an increased action of pancreatic monoamines [7] , the study was extended to fasted rats.
Materials and Methods
Sprague-Dawley rats, weighing 200-250 g, fed ~ t libitum or fasted for 24 hrs, were used for the preparation of the perfused isolated pancreas. The animals were anaesthetized by intraperitoneal injection of 50 mg/kg of pentobarbital, and the pancreas was isolated by a slight modification of the technique of Loubati6res et al. [8] . The pancreas was completely separated from adjacent organs and all vessels were carefully ligated. The gland was perfused with a Krebs-Ringer bicarbonate solution, containing 0.8 or 1.5 g/1 of glucose and 20 g/1 of beef albumin (fraction V, Armour Co). The final solution was adjusted to pH 7.4 with 0.1 N HCI, and then continuously gassed with a mixture of 95% oxygen and 5% carbon dioxide. The perfusate was administered into the coeliac artery and run into the prepared pancreas by an open circuit, non-recycling, perfusion system. The portal effluent was collected every 60 sec. Flow rates were kept approximately at 2.5 ml/min by making minor changes in arterial pressure. A 40 min equilibration period preceded the stimulatory concentration of glucose. Phentolamine (Regitine | Ciba) and adrenaline (Astra AB, S6dert~ilje, Sweden) were added to the perfusate as indicated in the figures.
Insulin was determined by a double-antibody radioimmunoassay using insulin reagent kits (Radiochemical Centre, Amersham) and a rat insulin standard, kindly provided by Dr. J. Schlichtkrull (Novo Research Institute, Copenhagen). The effect of phentolamine on insulin release was evaluated by comparison of the areas under the insulin curves. The initial phase of insulin corresponds to 0 to 7 min after the start of the infusion, while the second phase comprises the period beweeen 7 and 17 min.
Results
As seen in Fig. 1 , increasing the glucose concentration in the perfusate from 1.5 mg to 3.0 mg/ml was accompanied by a prominent and rapid insulin release. The peak insulin value was at 2 min, with a nadir at about 4 min, after which the insulin secretion rate continuously increased during glucose infusion. The addition of adrenaline at a concentration of 4 ng/ml markedly suppressed the glucose induced insulin release. This inhibition was counteracted by the alphaadrenergic blocking agent, phentolamine (10 ~tg/ml), which was added to the perfusate 5 rain after the application of adrenaline.
The effect of the above dose of phentolamihe on glucose induced insulin release, in the absence of adrenaline, is demonstrated in Fig. 2 , the left hand panel of which summarizes the experiments on fasted rats, while the right one gives the results obtained in rats fed ad libitum. In both types of experiments the equilibration medium contained 0.8 mg/ml of glucose. Glucose exerted a much more pronounced insulin release in the fed rats where the release rates both at the initial and second phase were more than three times those obtained in the fasted animals (p<0.005) ( Table 1) . Phentolamine significantly increased the insulinogenic effect of glucose independently of the nutritional state of the rats. This enhancement of the effect of glucose was about 100 per cent for the early as well as the late phase of insulin release (Table 1) .
Increasing the glucose concentration in the equilibration medium from 0.8 to 1.5 mg/ml in fasted rats almost doubled both the early and late phase of insulin release induced by 3.0 mg/ml of glucose (Fig. 3 , Table  1 ). Phentolamine exerted a quantitatively identical enhancing effect on glucose induced insulin release under these experimental conditions.
Insulin release after 40 min of equilibration was significantly higher in fed than in fasted rats (p< 0.01) ( Table 1) . Phentolamine significantly enhanced basal insulin release in both fed rats and fasted rats when the equilibration medium contained 1.5 mg/ml of glucose (Table 1) . phent ot ami ne g ucose Fig. 3 . Effect of phentolamine (10 ~tg/ml) on glucose induced insulin release in fasted rats. Experimental conditions as in Fig. 2 except that the equilibration medium contained 1.5 mg/ml of glucose
Discussion
It has been well established, in vivo as well as in vitro, that adrenaline is a potent inhibitor of insulin release via its alpha-adrenergic effect on the pancreatic beta-cell [1] [2] [3] [4] [5] . Recent reports suggest that catecholamines might also regulate insulin release under physiological conditions [4, 5] . Thus, Robertson and Porte [5] showed that administration of alphaadrenergic blockers stimulated, while beta-adrenergic blockers inhibited basal insulin secretion in man. We have previously demonstrated that the human pancreas is sensitive to small amounts of adrenaline [4] .
The above experiments were performed in vivo, which makes it difficult to estimate the relative efficiency of catecholamines liberated at the nerve endings of the islets and catecholamines reaching the pancreas via the circulation. The present findings, that phentoiamine enhanced glucose induced insulin secretion by approximately 100% in the isolated rat pancreas suggest that even tissue-bound pancreatic catecholamines may be of major significance in the regulation of insulin release. Although this statement is supported by the demonstration that the isolated pancreas may contain large quantities of catecholamines [6] , it cannot be excluded that the observed action of phentolamine on insulin release is a direct one on the B-cell, i.e., not mediated by the blockade of the suppression exerted by endogenous catecholamines.
In accordance with previous observations [4, [9] [10] [11] [12] [13] [14] , the present studies show that short-term fasting (24 h) was accompanied by decreased glucose induced insulin release. The kinetics of insulin release were not modified. This has also been demonstrated by Fink et al. [14] .
It has been shown that the impaired insulin release during fasting can be partially corrected by reserpine, and the possible role of pancreatic monoamines in the mediation of this derangement has been discussed [7] . In the present studies the defective insulin release after fasting could not be normalized by addition to the perfusate of the alpha-adrenergic blocking agent, phentolamine. Furthermore, phentolamine stimulated glucose induced insulin release to approximately the same extent in fed rats. Therefore, it is unlikely that catecholamines mediate the decreased insulin response to starvation.
Our experiments also show that, in fasted rats, a 40 min equilibration with a high glucose concentration (1.5 mg/ml) induced marked enhancement of basal insulin release. However, even under such conditions the response was significantly lower than that of fed rats given 0.8 mg/ml of glucose during the preincubation. This finding suggests that the defective glucose induced insulin release on fasting cannot be ascribed to lack of substrate at the initiation of the stimulation.
